Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder

British Journal of Psychiatry

Volumn 202, Issue 4, 2013, Pages 301-306

  Amsterdam, Jay D ^a   Luo, Lola ^a   Shults, Justine ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LITHIUM; PLACEBO;

ADULT; ARTICLE; BIPOLAR II DISORDER; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; FEMALE; HAZARD RATIO; HUMAN; HYPOMANIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MANIA; MONOTHERAPY; MOOD CHANGE; MOOD CONVERSION; NONRAPID CYCLING BIPOLAR DISORDER; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RAPID CYCLING BIPOLAR DISORDER; RECURRENT DISEASE; SAMPLE SIZE; SCORING SYSTEM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; YOUNG MANIA RATING SCALE;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; LITHIUM COMPOUNDS; MALE; RECURRENCE; TIME FACTORS;

EID: 84876172669     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.104711     Document Type: Article

References (34)

1. Oppenheim G. Drug-induced rapid cycling: possible outcomes and management. Am J Psychiatry 1982; 139: 939-41.
2. Coryell W, Solomon D, Turvey C, Keller M, Leon AC, Endicott J, et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003; 60: 914-20.
3. Koukopoulos A, Sani G, Koukopoulos AE, Minnai GP, Girardi P, Pani L, et al. Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affective Disord 2003; 73: 75-85.
4. Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003; 37: 297- 303.
5. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403-11.
6. Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand 2003; 108: 4-14.
7. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck Jr PE, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006; 163: 232-9.
8. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapidcycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 179-84.
9. Post RM, Kramlinger KG, Altshuler LL, Ketter T, Denicoff K. Treatment of rapid cycling bipolar illness. Psychopharmacol Bull 1990; 26: 37-47.
10. Ghaemi SN, Klara JR, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004; 161: 163-5.
11. Goldberg J, Ghaemi SN. Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression. Bipolar Disord 2005; 7 (suppl): 3-12.
12. Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001; 62: 612-6.
13. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 52: 1130-8.
14. Amsterdam JD, Wang CH, Schwarz M, Shults J. Initial therapy of rapid and non-rapid cycling patients with bipolar II major depressive episode. J Affect Disord 2009; 112: 219-30.
15. Kupfer DJ, Chengappa KNR, Gelenberg AJ, Hirschfeld RMA, Goldberg JF, Sachs GS, et al. Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry 2001; 62: 985-90.
16. Parker G, Tully L, Olley A, Hadzi-Pavlovic D. SSRIs as mood stabilizers for bipolar II disorder: a proof of concept study. J Affect Disord 2006; 92: 205-14.
17. Baldassano CF, Datto SM, Littman L, Lipari MA. What drugs are best for bipolar depression? Ann Clin Psychiatry 2003; 15: 225-32.
18. Yildiz A, Sachs GS. Do antidepressants induce rapidcycling? A gender-specific association. J Clin Psychiatry 2003; 64: 814-8.
19. Amsterdam JD, Shults J, Brunswick DJ, Hundert M. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate. Bipolar Disord 2004; 6: 75-81.
20. Amsterdam JD, Shults J. Fluoxetine monotherapy for bipolar type II and bipolar NOS major depression - a double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 2005; 20: 357-64.
21. Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar type II disorder - a randomized, double-blind, placebo-substitution trial. Am J Psychiatry 2010; 167: 792-800.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
23. Williams JBW. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988; 45: 742-7.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/PSY SCREEN). Biometrics Research, New York State Psychiatric Institute, 2001.
25. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-35.
26. Schneck CD, Miklowitz DJ, Miyahara S, Araga M, Wisniewski S, Gyulai L, et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2008; 165: 370-7.
27. McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, et al. Double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010; 71: 163-74.
28. Sidor MM, McQueen's GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry 2011; 72: 156-67.
29. Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP. Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry 1994; 164: 208-14.
30. Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001; 62: 612-6.
31. Bauer MS, Callahan AM, Jampala C, Petty F, Sajatovic M, Schaefer V, et al. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 1999; 60: 9-21.
32. Suppes T, Calabrese J, Mitchell P, Pazzaglia P, Potter W, Zarin D. Algorithms for the treatment of bipolar manic-depressive illness. Psychopharmacol Bull 1995; 31: 469-74.
33. Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL, The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry 1998; 59 (suppl 4): 73-9.
34. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The Expert Consensus Guidelines: Medication Treatment of Bipolar Disorder 2000. A Postgraduate Medicine Special Report. The McGraw-Hill Companies, 2000.